{
  "image_filename": "figure_p6_det_5_000.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p6_det_5_000.png",
  "image_type": "Figure",
  "page_number": 6,
  "block_id": "det_5_000",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A flowchart showing selection and exclusion of study participants aged 18\u201364 by vaccination type (recombinant vs standard-dose) over three influenza seasons (2018\u20132021), with counts at each exclusion step leading to the final cohorts. does not support the claim because the figure only details cohort selection numbers and does not present any data on immune response breadth or cross-protection in mismatch seasons",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A flowchart showing selection and exclusion of study participants aged 18\u201364 by vaccination type (recombinant vs standard-dose) over three influenza seasons (2018\u20132021), with counts at each exclusion step leading to the final cohorts.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure only details cohort selection numbers and does not present any data on immune response breadth or cross-protection in mismatch seasons",
    "confidence_notes": null
  }
}